Dividends & Buybacks ·
Profusa shareholders approve board discretion to effect reverse stock splits up to 1-for-12
NVACWProfusa, Inc.
On September 18, 2026, Profusa, Inc. held a Special Meeting of Stockholders where shareholders approved an amendment to the Certificate of Incorporation granting the Board discretion to effect one or more reverse stock splits within the next two years. The authorized range is 1-for-2 to 1-for-12, with the aggregate split not exceeding 1-for-12; specific ratios and timing remain at the Board's discretion without further shareholder approval. The proposal passed with 262,920 votes in favor against 17,360 opposed. Profusa, Inc. operates in the biotechnology industry, developing photobiomodulation therapies.